Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
6.24
-0.04 (-0.64%)
At close: Aug 29, 2025, 4:00 PM
6.32
+0.08 (1.28%)
After-hours: Aug 29, 2025, 7:01 PM EDT
Nyxoah Employees
Nyxoah had 184 employees as of December 31, 2024. The number of employees increased by 37 or 25.07% compared to the previous year.
Employees
184
Change (1Y)
37
Growth (1Y)
25.07%
Revenue / Employee
$31,554
Profits / Employee
-$493,791
Market Cap
217.30M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 184 | 37 | 25.07% |
| Dec 31, 2023 | 147 | 9 | 6.76% |
| Dec 31, 2022 | 138 | 32 | 29.96% |
| Dec 31, 2021 | 106 | 34 | 47.15% |
| Dec 31, 2020 | 72 | 29 | 69.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NYXH News
- 12 days ago - Nyxoah: High-Risk High-Reward Medtech To Own - Seeking Alpha
- 13 days ago - Nyxoah SA (NYXH) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Nyxoah Reports Second Quarter Financial and Operating Results - GlobeNewsWire
- 21 days ago - Nyxoah Announces Preliminary Results for the Second Quarter of 2025 - GlobeNewsWire
- 24 days ago - Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea - GlobeNewsWire
- 4 weeks ago - Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025 - GlobeNewsWire
- 5 weeks ago - Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine - GlobeNewsWire
- 2 months ago - Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025 - GlobeNewsWire